Home › Myeloproliferative Neoplasms › Texas › Houston

Pag-aaral pangklinika para sa Myeloproliferative Neoplasms sa Houston, TX

16 pag-aaral para sa Myeloproliferative Neoplasms ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Houston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Ben Taub General Hospital, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Nagre-recruitPhase 1

The University of Texas, MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07469891

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Texas Children's Hospital, Houston

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Nagre-recruitPhase 1/2

MD Anderson, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05320198

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Nagre-recruitPhase 1

M D Anderson Cancer Center, Houston

Edad 1 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT03630991

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Nagre-recruitPhase 2

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Nagre-recruitPhase 1/2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT03471260

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04493164

Project: Every Child for Younger Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
UT MD Anderson Cancer Center, Houston

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1

University of Texas M. D. Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07441694

Asciminib Roll-over Study

Nagre-recruitPhase 4

Uni Of TX MD Anderson Cancer Cntr, Houston

Edad 7 hanggang 100 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04877522

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT03589729

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1

Md Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06034002

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

MD Anderson, Houston

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Nagre-recruitPhase 1

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2025 · NCT05423691

Pag-aaral para sa Myeloproliferative Neoplasms sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.